1. HBW Insight
  2. >>Health
  3. >>Policy & Regulation
  4. >>Regulation

FDA Moves On NDA For First US OTC Birth Control, Scheduling Joint Ad Comm Meeting

 
• By Lauren Nardella

The US FDA has scheduled a joint advisory committee meeting for November to review Perrigo subsidiary HRA Pharma’s new drug application for Rx-to-OTC switch of Opill (0.075-mg norgestrel), which would represent the first birth control pill available in the US without a prescription.

The US market is one step closer to its first birth control pill available without a prescription as the US Food and Drug Administration announces a joint advisory committee meeting to review a new drug application for Rx-to-OTC switch of HRA Pharma’s Opill (0.075-mg norgestrel).

Published on 13 September in the Federal Register, FDA says it will hold a virtual meeting of the Nonprescription Drugs...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

‘You Are Very Regulated’: Consumer Health And Beauty Industries’ Attention Needed In California

 
• By Malcolm Spicer

Regulations likely holding consumer product firms’ attention include the Plastic Pollution Prevention and Packaging Producer Responsibility Act, SB 54, scheduled to become effective by 2027. “Easily the most significant, extended producer responsibility law ever to pass in the world,” says lobbyist

US FDA Independence Questioned At CDC Oversight Hearing

 
• By Michael McCaughan

A Senate committee is investigating leadership changes at the US Centers for Disease Control and Prevention. While the primary focus is vaccine policy, the first hearing suggested the probe could raise questions about FDA independence.

New UK Toothpaste Tubes Now 100% Recyclable

 
• By David Ridley

Haleon, Colgate-Palmolive and other manufacturers have changed the way they manufacturer toothpaste tubes to be sold in the UK so they can be all be technically recycled.

US FDA Facility Inspections, Website Reviews Paused With FY 2026 Budget On Hold

 
• By Malcolm Spicer

Continuing work includes “for cause and certain surveillance inspections of regulated facilities” and “criminal enforcement work and certain civil investigations” as White House mulls layoffs rather than furloughs during federal government shutdown.

More from Policy & Regulation

US FDA Independence Questioned At CDC Oversight Hearing

 
• By Michael McCaughan

A Senate committee is investigating leadership changes at the US Centers for Disease Control and Prevention. While the primary focus is vaccine policy, the first hearing suggested the probe could raise questions about FDA independence.

New UK Toothpaste Tubes Now 100% Recyclable

 
• By David Ridley

Haleon, Colgate-Palmolive and other manufacturers have changed the way they manufacturer toothpaste tubes to be sold in the UK so they can be all be technically recycled.

US FDA Program Encouraging Domestic Manufacturing May Be ‘Very Selective’

 
• By Sarah Karlin-Smith

Pharmaceutical manufacturers encouraged FDA to consider including expansions and modifications of existing US facilities in PreCheck program.